ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Survival"

  • 2017 American Transplant Congress

    Kidney Quality Dramatically Influences Patient and Death Censored Graft Survival in SLK Recipients.

    T. Zens, J. Danobeitia, P. Stahler, G. Leverson, R. Redfield, A. D'Alessandro, L. Fernandez.

    Department of Transplant Surgery, University of Wisconsin, Madison, WI

    Introduction: Renal grafts used in simultaneous kidney liver (SLK) transplants are allocated on “center based” arbitrary clinical criteria without entering the kidney allocation algorithm. The…
  • 2017 American Transplant Congress

    No Gains in Long-Term Survival Following Liver Transplantation Over the Past Three Decades.

    A. Rana,1 M. Kueht,1 J. Moffett,1 N. Galvan,1 R. Cotton,1 J. Vierling,1,2 A. Mindikoglu,1,2 C. O'Mahony,1 J. Goss.1

    1Surgery, Baylor College of Medicine, Houston; 2Hepatology, Baylor College of Medicine, Houston

    It is widely reported that outcomes have steadily improved in liver transplantation over the past 3 decades. The national benchmark of 1-year survival is now…
  • 2017 American Transplant Congress

    Complications Requiring Reoperation After Pediatric Liver Transplantation.

    D. Yoeli, J. Moffett, K. Hosek, R. Ackah, R. Sigireddi, M. Kueht, N. Galvan, R. Cotton, A. Rana, C. O'Mahony, J. Goss.

    Department of Surgery, Baylor College of Medicine, Houston, TX

    Context: Reoperative complications after liver transplantation have been shown to decrease patient and graft survival in adults; this effect, however, has not been studied in…
  • 2017 American Transplant Congress

    WHO Group II Pulmonary Hypertension Is Associated with Decreased Survival in Patients Awaiting Liver Transplantation.

    H. Memon, J.-A. Guerra, B. Trachtenberg, J. Estep, A. Bhimaraj, I. Hussain, M. Park, H. Monsour, M. Ghobrial, A. Guha.

    Medicine, Houston Methodist Hospital, Houston, TX

    End stage liver disease (ESLD) patients with cirrhotic cardiomyopathy often have WHO Group II pulmonary hypertension (PH), characterized by pulmonary capillary wedge pressure (PCWP) >15…
  • 2017 American Transplant Congress

    The Benefits of Pancreas After Kidney (PAK) Transplantation.

    M. Curry,1 J. Odorico,2 J. Fridell.3

    1Research, UNOs, Richmond, VA; 2Department of Surgery, University of Wisconsin, Madison, WI; 3Department of Surgery, Indiana University, Indianpolis, IN

    Background: PAK transplantation has been perceived as inferior to Simultaneous Pancreas and Kidney (SPK) transplantation with respect to patient and pancreas (PA) allograft survival. However,…
  • 2017 American Transplant Congress

    Impact of a B-Cell Targeting Agent on Antibody Mediated Rejection and Graft' Survival in Liver Transplantation with Preformed DSAs.

    A. Del Bello,1 V. Dubois,2 J. Dumortier,3 N. Congy-Jolivet,4 N. Kamar.1

    1Nephrology and Organ Transplant Department, CHU Toulouse, Toulouse, France; 2Department of Immunology, CHU Lyon, Lyon, France; 3Gastroenterology and Liver Transplant Department, CHU Lyon, Lyon, France; 4Department of Immunology, CHU Toulouse, Toulouse, France

    Introduction The negative impact of preformed anti-HLA donor specific antibodies (DSAs) in liver transplantation is clearly established. However, the potential interest of a B-cell depleting…
  • 2017 American Transplant Congress

    Third Liver Transplantation, Outcomes, and the Impact of Previous Graft Survival.

    M. Barry,1 M. Gupta,2 D. Goldberg,3 M. Levine,2 D. Simpson,2 K. Olthoff,2 A. Shaked,2 P. Abt.2

    1School of Medicine, University of Pennsylvania, Philadelphia, PA; 2Surgery, Division of Transplantation, University of Pennsylvania, Philadelphia, PA; 3Medicine, Division of Gastroenterology, University of Pennsylvania, Philadelphia, PA

    Introduction: Retransplantation with a third liver allograft is controversial with significant technical and medical challenges. National outcomes have not been described. We hypothesize that prior…
  • 2017 American Transplant Congress

    Survival Benefit of Kidney and/or Pancreas Transplantation for Patients with Type 1 Diabetes in the United States.

    R. Gruessner,1 M. Laftavi,1 O. Pankowycz,2 V. Whittaker,1 Z. Acun,1 V. Aggarwal,2 N. Ozden,2 A. Gruessner.1

    1Surgery, SUNY Upstate Medical University, Syracuse, NY; 2Internal Medicine, SUNY Upstate Medical University, Syracuse, NY

    Study Purpose: The purpose of this study was to determine the survival benefit of pancreas and/or kidney transplants as reported over a 28-year time period…
  • 2017 American Transplant Congress

    Is the Current Heart Allocation System Just and Fair for Blood Type O Recipients? – A Propensity-Matched Analysis of 34353 Patients in the UNOS Registry.

    M. Ando, K. Takeda, P. Kurlansky, M. Wright, C. Lee, J. Han, A. Garan, V. Topkara, M. Yuzefpolskaya, P. Colombo, M. Farr, Y. Naka, H. Takayama.

    Columbia University Medical Center, New York, NY

    Purpose: There is a known disparity between the waiting time on heart transplant (HTx) between blood type O and non-O recipients. This difference is mainly…
  • 2017 American Transplant Congress

    Glucocorticoid Receptor – Relaxin Signaling in Liver Transplant Ischemia-Reperfusion Injury (IRI): From Bench-to-Bedside.

    S. Kageyama,1 K. Nakamura,1 R. Sossa,2 E. Reed,2 N. Datta,1 A. Zarrinpar,1 R. Busuttil,1 J. Kupiec-Weglinski.1

    1The Dumont-UCLA Transplant Center, Department of Surgery, David Geffen School of Medicine at University of California, Los Angeles, CA; 2Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at University of California, Los Angeles, CA

    Background: Glucocorticoid receptor (GR) serves as a receptor for relaxin (RLX), a pregnancy hormone, with novel vasoactive and tissue remodeling properties. A phase III clinical…
  • « Previous Page
  • 1
  • …
  • 48
  • 49
  • 50
  • 51
  • 52
  • …
  • 66
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences